Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Cervical Cancer, April 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 269 articles:
HTML format


 

Single Articles

  1. AMIN FAS, Un Naher Z, Ali PSS
    Molecular markers predicting the progression and prognosis of human papillomavirus-induced cervical lesions to cervical cancer.
    J Cancer Res Clin Oncol. 2023 Mar 31. doi: 10.1007/s00432-023-04710.
    PubMed    
    Abstract available

  2. XU X, Shen L, Li W, Liu X, et al
    ITGA5 promotes tumor angiogenesis in cervical cancer.
    Cancer Med. 2023 Mar 31. doi: 10.1002/cam4.5873.
    PubMed    
    Abstract available

  3. CHENG Y, Geng L, Zhao L, Zuo P, et al
    [Corrigendum] Human papillomavirus E6‑regulated microRNA‑20b promotes invasion in cervical cancer by targeting tissue inhibitor of metalloproteinase 2.
    Mol Med Rep. 2023;27:101.
    PubMed    
    Abstract available

  4. YU W, Xiao C, Xu J, Jin J, et al
    Direct Dose Prediction With Deep Learning for Postoperative Cervical Cancer Underwent Volumetric Modulated Arc Therapy.
    Technol Cancer Res Treat. 2023;22:15330338231167039.
    PubMed    
    Abstract available

  5. VISIOLI CB, Giorgi Rossi P, Armaroli P, Iossa A, et al
    The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15-16 years in Italy.
    J Med Screen. 2023 Mar 30:9691413231165237. doi: 10.1177/09691413231165237.
    PubMed    
    Abstract available

  6. CHARROIS-DURAND C, Beauchemin MC, Barkati M
    A Case of Radiation-Induced Aortitis in a Patient With Cervical Cancer.
    Cureus. 2023;15:e35484.
    PubMed    
    Abstract available

  7. HAO Y, Guy MM, Liu Q, Li R, et al
    Construction of a prognostic model based on eight ubiquitination-related genes via machine learning and potential therapeutics analysis for cervical cancer.
    Front Genet. 2023;14:1142938.
    PubMed    
    Abstract available

  8. HE M, Guo M, Zhou Q, Tang Y, et al
    Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103).
    J Gynecol Oncol. 2023 Mar 23. doi: 10.3802/jgo.2023.
    PubMed    
    Abstract available

  9. LI M, Zhao C, Zhao Y, Li J, et al
    Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China.
    Front Immunol. 2023;14:1112750.
    PubMed    
    Abstract available

  10. SHISHKOVA K, Gergova R, Tasheva E, Shishkov S, et al
    Molecular Screening for High-Risk Human Papillomaviruses in Patients with Periodontitis.
    Viruses. 2023;15:809.
    PubMed    
    Abstract available

  11. ACEVEDO-SANCHEZ V, Martinez-Ruiz RS, Aguilar-Ruiz SR, Torres-Aguilar H, et al
    Quantitative Proteomics for the Identification of Differentially Expressed Proteins in the Extracellular Vesicles of Cervical Cancer Cells.
    Viruses. 2023;15:702.
    PubMed    
    Abstract available

  12. UMAKANTHAN S, Bukelo MM, Ghany S, Gay D, et al
    The Correlation of Papanicolaou Smears and Clinical Features to Identify the Common Risk Factors for Cervical Cancer: A Retrospective and Descriptive Study from a Tertiary Care Hospital in Trinidad.
    Vaccines (Basel). 2023;11:697.
    PubMed    
    Abstract available

  13. DAU H, Gottschlich A, Metz L, Pineda N, et al
    The role of daughters in relation to their mother's cervical cancer diagnosis and treatment in Guatemala: a descriptive study.
    BMC Womens Health. 2023;23:142.
    PubMed    
    Abstract available

  14. ZHU B, Yu H, Ni P, Chen X, et al
    A population-based cross-sectional study on the situation of cervical cancer screening in Liaoning, China.
    BMC Womens Health. 2023;23:144.
    PubMed    
    Abstract available

  15. LIU J, Wu D, Lin X, Hong Y, et al
    Retraction notice to "Long non-coding RNA TUG1 sponges microRNA-381-3p to facilitate cell viability and attenuate apoptosis in cervical cancer by elevating MDM2 expression" [Life Sci. 267 (2021) 118902].
    Life Sci. 2023 Mar 27:121600. doi: 10.1016/j.lfs.2023.121600.
    PubMed    


  16. HARIPRASAD R, John A, Abdulkader RS
    Challenges in the Implementation of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in India: A Systematic Review.
    JCO Glob Oncol. 2023;9:e2200401.
    PubMed    
    Abstract available

  17. KRISHNA A, Hasib AG, Fernandes D, Athiyamaan MS, et al
    Comparison of two high dose rate intracavitary brachytherapy regimens in treatment of cervical cancer: a preliminary report.
    Discov Oncol. 2023;14:33.
    PubMed    
    Abstract available

  18. LECHER JC, Didier HL, Dickson RL, Slaughter LR, et al
    Utilization of a cell-penetrating peptide-adaptor for delivery of human papillomavirus protein E2 into cervical cancer cells to arrest cell growth and promote cell death.
    Cancer Rep (Hoboken). 2023 Mar 28:e1810. doi: 10.1002/cnr2.1810.
    PubMed    
    Abstract available

  19. FERREIRA M, Gomes D, Neto M, Passarinha LA, et al
    Development and Characterization of Quercetin-Loaded Delivery Systems for Increasing Its Bioavailability in Cervical Cancer Cells.
    Pharmaceutics. 2023;15:936.
    PubMed    
    Abstract available

  20. JAYASINGHE YL, Tabrizi SN, Stevens M, Leong TY, et al
    Pre-Vaccination Human Papillomavirus Genotypes and HPV16 Variants among Women Aged 25 Years or Less with Cervical Cancer.
    Pathogens. 2023;12:451.
    PubMed    
    Abstract available

  21. SHAIKH R, Daniel A, Lyng FM
    Raman Spectroscopy for Early Detection of Cervical Cancer, a Global Women's Health Issue-A Review.
    Molecules. 2023;28:2502.
    PubMed    
    Abstract available

  22. GARGIULO ISACCO C, Balzanelli MG, Garzone S, Lorusso M, et al
    Alterations of Vaginal Microbiota and Chlamydia trachomatis as Crucial Co-Causative Factors in Cervical Cancer Genesis Procured by HPV.
    Microorganisms. 2023;11:662.
    PubMed    
    Abstract available

  23. FAN W, Lu Q, Liu G
    A Clinical Prediction Model of Overall Survival for Patients with Cervical Cancer Aged 25-69 Years.
    Medicina (Kaunas). 2023;59:600.
    PubMed    
    Abstract available

  24. CORTES-SARABIA K, Alarcon-Romero LDC, Mendoza-Catalan MA, Carpio-Pedroza JC, et al
    REST/NRSF Silencing Modifies Neuronal Gene Expression in siRNA-Treated HeLa Cells: A Preliminary Exploration in the Search for Neuronal Biomarkers of Cervical Cancer.
    Medicina (Kaunas). 2023;59:537.
    PubMed    
    Abstract available

  25. ZENG L, Sun X
    Correlation of INHBA Overexpression with Pathological Features, Antitumor Immune Response and Clinical Prognosis in Cervical Cancer.
    Medicina (Kaunas). 2023;59:495.
    PubMed    
    Abstract available

  26. JING W, Zhang R, Chen X, Zhang X, et al
    Association of Glycosylation-Related Genes with Different Patterns of Immune Profiles and Prognosis in Cervical Cancer.
    J Pers Med. 2023;13:529.
    PubMed    
    Abstract available

  27. PADEZNIK T, Oleksy A, Cokan A, Takac I, et al
    Changes in the Extracellular Matrix in Endometrial and Cervical Cancer: A Systematic Review.
    Int J Mol Sci. 2023;24:5463.
    PubMed    
    Abstract available

  28. AZAGE M, Zewudie S, Goedert MH, Hagos EG, et al
    Epidemiological Characteristics of Cancer Patients Attending at Felege Hiwot Referral Hospital, Northwest Ethiopia.
    Int J Environ Res Public Health. 2023;20:5218.
    PubMed    
    Abstract available

  29. SKJELDESTAD FE, Wergeland Sorbye S
    May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia?
    Int J Environ Res Public Health. 2023;20:4739.
    PubMed    
    Abstract available

  30. CHUA B, Lim LM, Ng JSY, Ma Y, et al
    Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore.
    Cancers (Basel). 2023;15:1812.
    PubMed    
    Abstract available

  31. CHEN X, Jiang M, Zhou S, Chen H, et al
    PRAME Promotes Cervical Cancer Proliferation and Migration via Wnt/beta-Catenin Pathway Regulation.
    Cancers (Basel). 2023;15:1801.
    PubMed    
    Abstract available

  32. DAPONTE N, Valasoulis G, Michail G, Magaliou I, et al
    HPV-Based Self-Sampling in Cervical Cancer Screening: An Updated Review of the Current Evidence in the Literature.
    Cancers (Basel). 2023;15:1669.
    PubMed    
    Abstract available

  33. ZHANG Y, Wu C, Xiao Z, Lv F, et al
    A Deep Learning Radiomics Nomogram to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer: A Two-Center Study.
    Diagnostics (Basel). 2023;13:1073.
    PubMed    
    Abstract available

  34. JI J, Pang W, Song J, Wang X, et al
    Retrospective Analysis of the Predictive Value of (18)F-FDG PET/CT Metabolic Parameters for PD-L1 Expression in Cervical Cancer.
    Diagnostics (Basel). 2023;13:1015.
    PubMed    
    Abstract available

  35. HUANG Q, Wang Y, Meng X, Li J, et al
    Amide Proton Transfer-Weighted Imaging Combined with ZOOMit Diffusion Kurtosis Imaging in Predicting Lymph Node Metastasis of Cervical Cancer.
    Bioengineering (Basel). 2023;10:331.
    PubMed    
    Abstract available

  36. ROCKWELL MS, Armbruster SD, Capucao JC, Russell KB, et al
    Reallocating Cervical Cancer Preventive Service Spending from Low to High-Value Clinical Scenarios.
    Cancer Prev Res (Phila). 2023 Mar 28:CAPR-22-0531.
    PubMed    
    Abstract available

  37. GAO Z, Zhao M, Yang X, Fu J, et al
    Assessment of Peripheral Platelet to Lymphocyte Ratio and Prognostic Nutritional Index in the Efficacy and Prognosis of Radiotherapy for Cervical Cancer.
    Curr Oncol. 2023;30:2834-2844.
    PubMed    
    Abstract available

  38. KC H, Gurung A, Katuwal M, Sharma R, et al
    Knowledge, Practice and Barriers on Cervical Cancer Screening among Married Women.
    J Nepal Health Res Counc. 2023;20:755-760.
    PubMed    
    Abstract available

  39. MIYOSHI AI, Ueda Y, Kurita T, Kimura T, et al
    Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
    Anticancer Res. 2023;43:1397-1405.
    PubMed    
    Abstract available

  40. TOITA T, Wada K, Sutani S, Umezawa R, et al
    Definitive radiotherapy consisting of external beam radiotherapy without central shielding and 3D image-guided brachytherapy for patients with cervical cancer: feasibility for Japanese patients and dose-response analyses for local control in the low-d
    Jpn J Clin Oncol. 2023 Mar 27:hyad022. doi: 10.1093.
    PubMed    
    Abstract available

  41. HORIO F, Ikeda T, Zaitsu M, Takebe D, et al
    Knowledge and Awareness of Human Papillomavirus Vaccination and Cervical Cancer among Men and Women in Japan: A Questionnaire Survey.
    Asian Pac J Cancer Prev. 2023;24:1063-1071.
    PubMed    
    Abstract available

  42. JOHAN SK, Lobo D, Athiyamaan MS, Srinivas C, et al
    In-vivo Comparison of Planned and Measured Rectal Doses during Cobalt-60 HDR CT-based Intracavitary Brachytherapy Applications of Cervical Cancer Using the PTW 9112 Semiconductor Probe.
    Asian Pac J Cancer Prev. 2023;24:897-907.
    PubMed    
    Abstract available

  43. SURENDRAN S, Foo C, Tan DHY, Tan WH, et al
    Understanding Barriers and Facilitators of Breast and Cervical Cancer Screening among Singapore Women: A Qualitative Approach.
    Asian Pac J Cancer Prev. 2023;24:889-895.
    PubMed    
    Abstract available

  44. CAMPANER AB, Fernandes GL
    Evaluation of 1,030,482 Cervical Smear Results in Brazilian Population.
    Asian Pac J Cancer Prev. 2023;24:867-872.
    PubMed    
    Abstract available

  45. LIN Y, Zhang R, Pan H, Li Y, et al
    A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer.
    Med Sci Monit. 2023;29:e938660.
    PubMed    
    Abstract available

  46. ADEGBOYEGA A, Adeyimika D, Omoadoni O, Mark D, et al
    HPV vaccination and cervical cancer screening promotion among Black individuals: social ecological perspectives from key informants interviews.
    Ethn Health. 2023 Mar 27:1-15. doi: 10.1080/13557858.2023.2193360.
    PubMed    
    Abstract available

  47. PLAISY MK, Boni SP, Coffie PA, Tanon A, et al
    Barriers to early diagnosis of cervical cancer: a mixed-method study in Cote d'Ivoire, West Africa.
    BMC Womens Health. 2023;23:135.
    PubMed    
    Abstract available

  48. LIN W, Huang W, Mei C, Liu P, et al
    Associations between the signing status of family doctor contract services and cervical cancer screening behaviors: a cross-sectional study in Shenzhen, China.
    BMC Public Health. 2023;23:573.
    PubMed    
    Abstract available

  49. TANG FT, Ji J, Ding J, Ke F, et al
    [Cervical gastric-type adenocarcinomas with enteroblastoid characteristic: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2023;52:417-420.
    PubMed    


  50. SHI L, Zhang D, Han H, Zhang L, et al
    HOTAIR knockdown impairs metastasis of cervical cancer cells by down-regulating metastasis-related genes.
    J Obstet Gynaecol. 2023;43:2181060.
    PubMed    
    Abstract available

  51. XU HF, Zhao XL, Zhao S, Hu SY, et al
    Clinical performance of a newly developed domestic urine-based HPV test for cervical cancer screening in China.
    J Med Virol. 2023 Mar 27. doi: 10.1002/jmv.28705.
    PubMed    
    Abstract available

  52. XIA J, Chen GY, Li YY, Chen L, et al
    Rapid and sensitive detection of superoxide dismutase in serum of the cervical cancer by 4-aminothiophenol-functionalized bimetallic Au-Ag nanoboxs array.
    Front Bioeng Biotechnol. 2023;11:1111866.
    PubMed    
    Abstract available

  53. MUTYALA S, Smith G, Ansinelli H, Thawani N, et al
    Feasibility of outpatient hybrid brachytherapy for cervical cancer with minimal sedation: Results from a single-institutional protocol.
    J Contemp Brachytherapy. 2023;15:43-47.
    PubMed    
    Abstract available

  54. FROHLICH G, Vizkeleti J, Nguyen AN, Polgar C, et al
    Are active dwell positions always necessary in the ring/ovoids channel of the cervical applicator in the intracavitary-interstitial brachytherapy of cervical cancer?
    J Contemp Brachytherapy. 2023;15:48-56.
    PubMed    
    Abstract available

  55. KANANI A, Owrangi A, Yazdi M, Fatemi-Ardekani A, et al
    Development of a multi-purpose quality control phantom for MRI-based treatment planning in high-dose-rate brachytherapy of cervical cancer.
    J Contemp Brachytherapy. 2023;15:57-68.
    PubMed    
    Abstract available

  56. FAIVRE JC, Jung P, Salleron J, Baumard F, et al
    Prognostic factors of local control and progression-free survival in AJCC stages T1 and T2 cervical cancer patients treated with adjuvant brachytherapy after chemoradiotherapy.
    J Contemp Brachytherapy. 2023;15:27-36.
    PubMed    
    Abstract available

  57. LI X, Du M, Zuo S, Zhou M, et al
    Deep convolutional neural networks using an active learning strategy for cervical cancer screening and diagnosis.
    Front Bioinform. 2023;3:1101667.
    PubMed    
    Abstract available

  58. YAO S, Zhao L, Chen S, Wang H, et al
    Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapy.
    Front Immunol. 2023;14:1135657.
    PubMed    
    Abstract available

  59. CRUZ-VALDEZ A, Palacio-Mejia LS, Quezada-Sanchez AD, Hernandez-Avila JE, et al
    Cervical cancer prevention program in Mexico disrupted due to COVID-19 pandemic: Challenges and opportunities.
    Front Oncol. 2023;13:1008560.
    PubMed    
    Abstract available

  60. KULKARNI SP, Paliwal S, Kosta S
    Genotypic Diversity of Human Papillomavirus (HPV) Types and Its Prevalence With Cervical Cancer (CC) in Central India.
    Cureus. 2023;15:e35227.
    PubMed    
    Abstract available

  61. CHEN G, Hong X, He W, Ou L, et al
    The construction and analysis of tricarboxylic acid cycle related prognostic model for cervical cancer.
    Front Genet. 2023;14:1092276.
    PubMed    
    Abstract available

  62. GUO C, Qu X, Tang X, Song Y, et al
    Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: Integrating single-cell RNA-sequencing and spatial transcriptome
    Clin Transl Med. 2023;13:e1219.
    PubMed    
    Abstract available

  63. AHMED B, Abushama M, Konje JC
    Prevention of spontaneous preterm delivery - an update on where we are today.
    J Matern Fetal Neonatal Med. 2023;36:2183756.
    PubMed    
    Abstract available

  64. HU K, Wang J, Sparen P, Herweijer E, et al
    Invasive cervical cancer, precancerous lesions, and cervical screening participation among women with mental illness in Sweden: a population-based observational study.
    Lancet Public Health. 2023;8:e266-e275.
    PubMed    
    Abstract available

  65. BATESON D, Woo YL, Kulkarni J
    Elimination of cervical cancer: ensuring equity.
    Lancet Public Health. 2023;8:e248-e249.
    PubMed    


  66. YARANDI F, Shirali E, Feizabad E, Ramhormoziyan S, et al
    Cervical intraepithelial neoplasia in non-16/18 high-risk human papilloma virus positive/cytology negative women: An alternative approach in poor resource areas.
    Taiwan J Obstet Gynecol. 2023;62:299-303.
    PubMed    
    Abstract available

  67. ZHANG X, Zhu L, Wang X, Zhang H, et al
    Basic research on curcumin in cervical cancer: Progress and perspectives.
    Biomed Pharmacother. 2023;162:114590.
    PubMed    
    Abstract available

  68. MEGERSA T, Dango S, Kumsa K, Lemma K, et al
    Prevalence of high-risk human papillomavirus infections and associated factors among women living with HIV in Shashemene town public health facilities, Southern Ethiopia.
    BMC Womens Health. 2023;23:125.
    PubMed    
    Abstract available

  69. KESIC V, Carcopino X, Preti M, Vieira-Baptista P, et al
    The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus S
    J Low Genit Tract Dis. 2023;27:131-145.
    PubMed    
    Abstract available

  70. CLAY PA, Thompson TD, Markowitz LE, Ekwueme DU, et al
    Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States.
    Vaccine. 2023 Mar 10:S0264-410X(23)00184-6. doi: 10.1016/j.vaccine.2023.
    PubMed    
    Abstract available

  71. WEI Y, Lin S, Zhi W, Chu T, et al
    Genomic analysis of cervical carcinoma identifies Alpelisib as a therapeutic option for PIK3CA-mutant cervical carcinoma via the PI3K/AKT pathway.
    J Med Virol. 2023;95:e28656.
    PubMed    
    Abstract available

  72. AL ALAWI S, Al Zaabi O, Heffernan ME, Arulappan J, et al
    Knowledge, attitudes and acceptance toward Human papillomavirus (HPV) vaccination: Perspectives of Muslim women and men.
    Vaccine. 2023 Feb 27:S0264-410X(23)00217-7. doi: 10.1016/j.vaccine.2023.
    PubMed    
    Abstract available

  73. SKELIN J, Dukic A, Filic V, Hufbauer M, et al
    MAML1-induced HPV E6 oncoprotein stability is required for cellular proliferation and migration of cervical tumor-derived cells.
    J Med Virol. 2023;95:e28624.
    PubMed    
    Abstract available

  74. LIN G, Li J
    Circulating HPV DNA in HPV-associated cancers.
    Clin Chim Acta. 2023;542:117269.
    PubMed    
    Abstract available

  75. HUGHES KC, Herring TA, Song JN, Gately RV, et al
    Cervical High-Grade Squamous Intraepithelial Lesion Burden and Standard of Care Treatment Effectiveness and Safety in the United States, 2008-2018: The EACH-WOMAN Project.
    J Low Genit Tract Dis. 2023;27:105-112.
    PubMed    
    Abstract available

  76. LIANG HY, Chen SL, Cai SH, Zhang SW, et al
    CMTM6 recruits T cells within the endocervical adenocarcinoma microenvironment and suppresses cell proliferation via the p53 pathway.
    J Med Virol. 2023;95:e28605.
    PubMed    
    Abstract available

  77. LIU Y, Li T, Guo R, Chen T, et al
    The vaginal microbiota among the different status of human papillomavirus infection and bacterial vaginosis.
    J Med Virol. 2023;95:e28595.
    PubMed    
    Abstract available

  78. MORELLO L, Mancini J, Carcopino X
    Predictors factors of the absence of high-grade intraepithelial lesion in excisional therapy specimen.
    J Gynecol Obstet Hum Reprod. 2023;52:102550.
    PubMed    
    Abstract available

  79. WATSON CH, Spinosa D, Hayes T, Scott A, et al
    A Pilot Study of a Screening Program for Human Papillomavirus-Related Squamous Intraepithelial Lesion and Malignancy in Gynecologic Oncology Patients.
    J Low Genit Tract Dis. 2023;27:120-124.
    PubMed    
    Abstract available

  80. DEL VECCHIO NJ, Beaber EF, Garcia MP, Wheeler CM, et al
    Provider- and Facility-Level Variation in Precancerous Cervical Biopsy Diagnoses.
    J Low Genit Tract Dis. 2023;27:113-119.
    PubMed    
    Abstract available

  81. CHANG X, Miao J
    Ferroptosis: Mechanism and potential applications in cervical cancer.
    Front Mol Biosci. 2023;10:1164398.
    PubMed    
    Abstract available

  82. HUANG XD, Huo LQ, Luo YS, Chen K, et al
    Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer.
    Ther Adv Med Oncol. 2023;15:17588359231165974.
    PubMed    
    Abstract available

  83. NICKSON C, Smith MA, Feletto E, Velentzis LS, et al
    A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia.
    Elife. 2023;12:e82818.
    PubMed    
    Abstract available

  84. LIANG H, Xiang L, Wu H, Liu Y, et al
    Anoikis-related long non-coding RNA signatures to predict prognosis and small molecular drug response in cervical cancer.
    Front Pharmacol. 2023;14:1135626.
    PubMed    
    Abstract available

  85. CHEN J, Ma N, Sun M, Chen L, et al
    Prognostic value of apparent diffusion coefficient in neuroendocrine carcinomas of the uterine cervix.
    PeerJ. 2023;11:e15084.
    PubMed    
    Abstract available

  86. SAVAS LS, Loomba P, Shegog R, Alaniz A, et al
    Using Implementation Mapping to increase uptake and use of Salud en Mis Manos: A breast and cervical cancer screening and HPV vaccination intervention for Latinas.
    Front Public Health. 2023;11:966553.
    PubMed    
    Abstract available

  87. LI T, Feng R, Chen B, Zhou J, et al
    EREG is a risk factor for the prognosis of patients with cervical cancer.
    Front Med (Lausanne). 2023;10:1161835.
    PubMed    
    Abstract available

  88. WANG Y, Chuan J, Zhu B, Zu Y, et al
    Evaluation of PAX1/ST6GALNAC5 methylation as a triage test for cervical intraepithelial neoplasia and cervical cancer.
    Epigenomics. 2023 Apr 5. doi: 10.2217/epi-2022-0396.
    PubMed    
    Abstract available

  89. LILLIECREUTZ C, Holm ACS, Dahlgren MA, Blomberg M, et al
    Student-led clinic cervical cancer screening-medical students' views on progression of learning, quality of Pap smears and women s experiences of the visit - a mixed methods study.
    BMC Med Educ. 2023;23:218.
    PubMed    
    Abstract available

  90. MUTURI D, Mwanzi SN, Riunga FM, Shah J, et al
    HIV Prevalence and Characteristics Among Patients With AIDS-Defining and Non-AIDS-Defining Cancers in a Tertiary Hospital in Kenya.
    JCO Glob Oncol. 2023;9:e2200360.
    PubMed    
    Abstract available

  91. SSEDYABANE F, Ngonzi J, Kajabwangu R, Najjuma JN, et al
    Association between obesity and cervical intraepithelial neoplasia: results from a case control study in south western Uganda.
    BMC Womens Health. 2023;23:159.
    PubMed    
    Abstract available

  92. DE RIBAMAR ROSS J, Marinelli NP, Vidal FCB, da Costa Fraga E, et al
    Frequency of human papilomavirus and associated factors in gypsy and quilombola women : Human papillomavirus in gypsy and quilombola women.
    BMC Womens Health. 2023;23:160.
    PubMed    
    Abstract available

  93. TODA Y, Morimoto T, Hirata H, Yoshihara T, et al
    Letter to the Editor concerning "Incidence and risk factors associated with the development of metastatic spinal cord compression due to bone metastasis in women with cervical cancer" by A. Grasso Giglio, et al. (Eur Spine J [2022]: doi:10.1007/s00586
    Eur Spine J. 2023 Apr 4. doi: 10.1007/s00586-023-07656.
    PubMed    


  94. EAKIN A, Wairiri L, Stadtlander W, Bruegl A, et al
    Identifying disparities in brachytherapy delivery for locally advanced cervical cancer.
    Brachytherapy. 2023 Apr 2:S1538-4721(23)00025.
    PubMed    
    Abstract available

  95. WALTER AE, Cosper PF, Nickel KP, Ramesh S, et al
    Biological Characterization of the Effects of Filtration on the Xoft Axxent(R) Electronic Brachytherapy Source for Cervical Cancer Applications.
    Radiat Res. 2023 Apr 4. doi: 10.1667/RADE-22-00112.
    PubMed    
    Abstract available

  96. WU PJ, Chiou HL, Hsieh YH, Lin CL, et al
    Induction of immunogenic cell death effect of licoricidin in cervical cancer cells by enhancing endoplasmic reticulum stress-mediated high mobility group box 1 expression.
    Environ Toxicol. 2023 Apr 4. doi: 10.1002/tox.23793.
    PubMed    
    Abstract available

  97. NINSIIMA M, Nyabigambo A, Kagaayi J
    Acceptability of integration of cervical cancer screening into routine HIV care, associated factors and perceptions among HIV-infected women: a mixed methods study at Mbarara Regional Referral Hospital, Uganda.
    BMC Health Serv Res. 2023;23:333.
    PubMed    
    Abstract available

  98. QIU J, Chen X
    Acquired vulvar lymphangioma circumscriptum after cervical cancer.
    Pan Afr Med J. 2023;44:29.
    PubMed    


  99. SHANG F, Tan Z, Gong T, Tang X, et al
    Evaluation of parametrial infiltration in patients with IB-IIB cervical cancer by a radiomics model integrating features from tumoral and peritumoral regions on (18) F-FDG PET/MRI images.
    NMR Biomed. 2023 Apr 3:e4945. doi: 10.1002/nbm.4945.
    PubMed    
    Abstract available

  100. OKETCH SY, Ochomo EO, Orwa JA, Mayieka LM, et al
    Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: a systematic review and meta-analysis.
    BMJ Open. 2023;13:e067164.
    PubMed    
    Abstract available

  101. LIU H, Ma H, Li Y, Zhao H, et al
    Advances in epigenetic modifications and cervical cancer research.
    Biochim Biophys Acta Rev Cancer. 2023 Apr 1:188894.
    PubMed    
    Abstract available

  102. A D, Bi H, Zhang D, Xiao B, et al
    Association between human papillomavirus infection and common sexually transmitted infections, and the clinical significance of different Mycoplasma subtypes.
    Front Cell Infect Microbiol. 2023;13:1145215.
    PubMed    
    Abstract available

  103. LIAO D, Liu X, He L, Yao Y, et al
    Comprehensive bioinformatics analysis of the expression, prognostic value, and immune infiltration of chromobox family members in cervical cancer.
    Iran J Basic Med Sci. 2023;26:468-477.
    PubMed    
    Abstract available

  104. GAO D, Zhao G, Di J, Zhang X, et al
    Knowledge of Cervical Cancer and HPV, and Willingness to Receive HPV Vaccination Among 20-45-Year-Old Women - Six Provinces, China, 2018.
    China CDC Wkly. 2023;5:201-205.
    PubMed    
    Abstract available

  105. GRAU-BEJAR JF, Garcia-Duran C, Garcia-Illescas D, Mirallas O, et al
    Advances in immunotherapy for cervical cancer.
    Ther Adv Med Oncol. 2023;15:17588359231163836.
    PubMed    
    Abstract available

  106. LIU J, Li S, Cao Q, Zhang Y, et al
    Risk factors for the recurrence of cervical cancer using MR-based T1 mapping: A pilot study.
    Front Oncol. 2023;13:1133709.
    PubMed    
    Abstract available

  107. SURYADEVARA A, Gundu DK, Kuppa P, Chinta SK, et al
    The selection of tandem angle and imaging during intracavitary brachytherapy of carcinoma cervix - An experience from a regional cancer center.
    J Cancer Res Ther. 2023;19:235-240.
    PubMed    
    Abstract available

  108. LI K, Yin R
    Opportunistic cervical cancer screening for elderly women without standardized screening.
    J Cancer Res Ther. 2023;19:92-96.
    PubMed    
    Abstract available

  109. CHENG H, Wang L, Wang L, Li Q, et al
    Discussion on the necessity of bilateral inguinal lymphatic area irradiation for cervical cancer with invasion of the lower one-third of the vagina.
    J Cancer Res Ther. 2023;19:20-24.
    PubMed    
    Abstract available

  110. GAUNA F, Verger P, Fressard L, Jardin M, et al
    Vaccine hesitancy about the HPV vaccine among French young women and their parents: a telephone survey.
    BMC Public Health. 2023;23:628.
    PubMed    
    Abstract available

  111. ZHONG G, Zhao Q, Chen Z, Yao T, et al
    TGF-beta signaling promotes cervical cancer metastasis via CDR1as.
    Mol Cancer. 2023;22:66.
    PubMed    
    Abstract available

  112. CINTRA FRE, Araujo LM, Dib MI, Brollo LCS, et al
    Cervical Cancer Screening Is a Highly Neglected Procedure Among Women With Systemic Lupus Erythematosus.
    J Rheumatol. 2023 Apr 1:jrheum.230082. doi: 10.3899/jrheum.230082.
    PubMed    
    Abstract available

  113. AO M, Li P, Sun D, Li X, et al
    Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent chemoradiotherapy.
    J Obstet Gynaecol. 2023;43:2179915.
    PubMed    
    Abstract available

  114. BURKI TK
    India rolls out HPV vaccination.
    Lancet Oncol. 2023;24:e147.
    PubMed    


  115. COLE K, Al-Kadhimi Z, Talmadge JE
    Highlights into historical and current immune interventions for cancer.
    Int Immunopharmacol. 2023;117:109882.
    PubMed    
    Abstract available

  116. CHEN J, Wang D, Wang Z, Wu K, et al
    Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.
    J Virol. 2023;97:e0181922.
    PubMed    
    Abstract available

  117. JORDA P, Hullot J, Crouzet A, Poteau A, et al
    [Psychological impact of the announcement of an abnormal cervical smear: How to improve patient experience and information? COLANX: a multicenter study in Seine-Maritime].
    Gynecol Obstet Fertil Senol. 2023;51:193-199.
    PubMed    
    Abstract available

  118. POISEUIL M, Moutel G, Cosson M, Quertier MC, et al
    Participation in breast cancer screening and its influence on other cancer screening invitations: study in women aged 56 years old in four French departments.
    Eur J Cancer Prev. 2023;32:238-245.
    PubMed    
    Abstract available

  119. NISHIO S
    Current status and molecular biology of human papillomavirus-independent gastric-type adenocarcinoma of the cervix.
    J Obstet Gynaecol Res. 2023;49:1106-1113.
    PubMed    
    Abstract available

  120. QIU J, Qu X, Wang Y, Guo C, et al
    Single-Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus-Associated (HPVA) and Non-HPVA Adenocarcinoma.
    Adv Sci (Weinh). 2023;10:e2204951.
    PubMed    
    Abstract available

  121. YABUKI Y
    Two lateral parametria in radical hysterectomy: History and outcome.
    J Obstet Gynaecol Res. 2023;49:1069-1078.
    PubMed    
    Abstract available

  122. ZHEN L, Pan W
    ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via an m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma.
    Clin Exp Pharmacol Physiol. 2023;50:380-392.
    PubMed    
    Abstract available

  123. ESPINOZA-GUTARRA MR, Rawl SM, Maupome G, O'Leary HA, et al
    Cancer-related knowledge, beliefs, and behaviors among Hispanic/Latino residents of Indiana.
    Cancer Med. 2023;12:7470-7484.
    PubMed    
    Abstract available

  124. TSAMPAZIS N, Vavoulidis E, Siarkou CM, Siarkou GM, et al
    Diagnostic comparison of electrical impedance spectroscopy with colposcopy and HPV mRNA-testing in the prediction of CIN2+ women in Greece.
    J Obstet Gynaecol Res. 2023;49:1222-1229.
    PubMed    
    Abstract available

  125. RASOOL S, Naz F, Abdul Wahab T, Khidri FF, et al
    Frequency of abnormal Pap smear in patients presenting with postcoital bleeding in Tertiary Care Hospital, Karachi, Pakistan.
    Trop Doct. 2023;53:267-270.
    PubMed    
    Abstract available

  126. DENG S, Qian L, Liu L, Liu H, et al
    Circular RNA ARHGAP5 inhibits cisplatin resistance in cervical squamous cell carcinoma by interacting with AUF1.
    Cancer Sci. 2023;114:1582-1595.
    PubMed    
    Abstract available

  127. EINSTEIN MH, Roden RBS, Ferrall L, Akin M, et al
    Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1.
    Cancer Prev Res (Phila). 2023;16:219-227.
    PubMed    
    Abstract available

  128. HUANG J, Wei Y, Gu L, Di W, et al
    Feasibility study of 5-aminolevulinic acid mediated photodynamic therapy of persistent vaginal high-risk HPV infection of post-hysterectomy patients.
    Photodiagnosis Photodyn Ther. 2023;41:103250.
    PubMed    
    Abstract available

  129. LAHLOU ND, Kaibech M, Bakkali T, Zoulati M, et al
    [Intracardiac migration of the ureteral single-J : A case report and removal techniques].
    Ann Cardiol Angeiol (Paris). 2023;72:101577.
    PubMed    
    Abstract available

  130. FRUMOVITZ M, Chisholm GB, Jhingran A, Ramalingam P, et al
    Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study.
    Am J Obstet Gynecol. 2023;228:445.
    PubMed    
    Abstract available

  131. LIU A, Garcia-Torres LC, Johnson C, Haver MK, et al
    Cancer screening educational interventions in rural and farmworker communities: a systematic literature review.
    Ethn Health. 2023;28:335-357.
    PubMed    
    Abstract available

  132. ANSARI B
    Information seeking behaviour differences indicate which US population groups lack information about human papilloma virus and associated cancer risks.
    Health Info Libr J. 2023;40:42-53.
    PubMed    
    Abstract available

  133. HUANG Y, Wen W, Li X, Xu D, et al
    Prognostic value of lymphovascular space invasion in stage IA to IIB cervical cancer: A meta-analysis.
    Medicine (Baltimore). 2023;102:e33547.
    PubMed    
    Abstract available

  134. AHN JH, Yun J, Yun CY, Yoo JG, et al
    Is there a relationship between surgical proficiency and oncologic outcome of minimally invasive radical hysterectomy for early-stage cervical cancer?
    Int J Med Sci. 2023;20:551-556.
    PubMed    
    Abstract available

  135. MENG Y, Yan X, Fan J
    Construction of prediction model of lymph node metastasis of early cervical cancer based on machine learning algorithm and its application: experience of 204 cases in a single center.
    Am J Transl Res. 2023;15:1852-1861.
    PubMed    
    Abstract available

  136. PING P, Li J, Lei H, Xu X, et al
    Fatty acid metabolism: A new therapeutic target for cervical cancer.
    Front Oncol. 2023;13:1111778.
    PubMed    
    Abstract available

  137. O PATHAK S, M Manohar S
    Molecular milieu of autophagy in cervical cancer and its therapeutic implications.
    Curr Cancer Drug Targets. 2023 Apr 12. doi: 10.2174/1568009623666230412104913.
    PubMed    
    Abstract available

  138. ZHAO L, Geng R, Huang Y, Zhang J, et al
    AP2alpha negatively regulates PDHA1 in cervical cancer cells to promote aggressive features and aerobic glycolysis in vitro and in vivo.
    J Gynecol Oncol. 2023 Apr 5. doi: 10.3802/jgo.2023.
    PubMed    
    Abstract available

  139. ZHANG ZF, Liu F, Zhang HR, Liu B, et al
    Upregulation of TMEM40 is associated with the malignant behavior and promotes tumor progression in cervical cancer.
    Discov Oncol. 2023;14:43.
    PubMed    
    Abstract available

  140. WANG C, Lester B, Huang L, Sun S, et al
    Patient, disease, and survival outcomes for stage IB to stage IV cervical cancer-A population study.
    Womens Health (Lond). 2023;19:17455057231164551.
    PubMed    
    Abstract available

  141. CHEN Q, Shen S, Lv N, Tong J, et al
    Role of microRNAs in glycolysis in gynecological tumors (Review).
    Int J Oncol. 2023;62:63.
    PubMed    
    Abstract available

  142. BAIG E, Furqan A, Abid M
    Do it yourself cervical cancer test: A gateway to increase cervical cancer screening in Pakistan.
    J Pak Med Assoc. 2023;73:955.
    PubMed    


  143. TEHRIM M, Kumari B, Memon A
    HPV: take the test, not the risk. Be wise, immunize.
    J Pak Med Assoc. 2023;73:947.
    PubMed    


  144. ZOU M, Liu H, Liu H, Wang M, et al
    Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China.
    Front Immunol. 2023;14:1119566.
    PubMed    
    Abstract available

  145. TERZIC M, Makhadiyeva D, Bila J, Andjic M, et al
    Reproductive and Obstetric Outcomes after Fertility-Sparing Treatments for Cervical Cancer: Current Approach and Future Directions.
    J Clin Med. 2023;12:2614.
    PubMed    
    Abstract available

  146. CORTES-MORALES VA, Chavez-Sanchez L, Rocha-Zavaleta L, Espindola-Garibay S, et al
    Mesenchymal Stem/Stromal Cells Derived from Cervical Cancer Promote M2 Macrophage Polarization.
    Cells. 2023;12:1047.
    PubMed    
    Abstract available

  147. ALI H, Traj P, Szebeni GJ, Gemes N, et al
    Investigation of the Antineoplastic Effects of 2-(4-Chlorophenyl)-13alpha-Estrone Sulfamate against the HPV16-Positive Human Invasive Cervical Carcinoma Cell Line SiHa.
    Int J Mol Sci. 2023;24:6625.
    PubMed    
    Abstract available

  148. DOVNIK A, Poljak M
    The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions.
    Int J Mol Sci. 2023;24:6479.
    PubMed    
    Abstract available

  149. LEE S, Jung H, Park J, Ahn J, et al
    Accurate Prediction of Cancer Prognosis by Exploiting Patient-Specific Cancer Driver Genes.
    Int J Mol Sci. 2023;24:6445.
    PubMed    
    Abstract available

  150. RAZLOG R, Kruger CA, Abrahamse H
    Cytotoxic Effects of Combinative ZnPcS(4) Photosensitizer Photodynamic Therapy (PDT) and Cannabidiol (CBD) on a Cervical Cancer Cell Line.
    Int J Mol Sci. 2023;24:6151.
    PubMed    
    Abstract available

  151. SALMERON-BARCENAS EG, Mendoza-Catalan MA, Ramirez-Bautista AU, Lozano-Santos RA, et al
    Identification of Mir-182-3p/FLI-1 Axis as a Key Signaling in Immune Response in Cervical Cancer: A Comprehensive Bioinformatic Analysis.
    Int J Mol Sci. 2023;24:6032.
    PubMed    
    Abstract available

  152. DITTO A, Leone Roberti Maggiore U, Evangelisti G, Bogani G, et al
    Diagnostic Accuracy of Magnetic Resonance Imaging in the Pre-Operative Staging of Cervical Cancer Patients Who Underwent Neoadjuvant Treatment: A Clinical-Surgical-Pathologic Comparison.
    Cancers (Basel). 2023;15:2061.
    PubMed    
    Abstract available

  153. KALBHOR M, Shinde S, Popescu DE, Hemanth DJ, et al
    Hybridization of Deep Learning Pre-Trained Models with Machine Learning Classifiers and Fuzzy Min-Max Neural Network for Cervical Cancer Diagnosis.
    Diagnostics (Basel). 2023;13:1363.
    PubMed    
    Abstract available

  154. MATTIS A, Beydoun H, Dobrydneva Y, Ganjoo R, et al
    Investigating the Efficacy of HPV Vaccines in Preventing Cervical Cancer from 2006 to 2018 in the US: A SEER Data Set Analysis.
    Rev Recent Clin Trials. 2023 Apr 10. doi: 10.2174/1574887118666230410093715.
    PubMed    
    Abstract available

  155. CARTWRIGHT K, Kosich M, Gonya M, Kanda D, et al
    Cervical Cancer Knowledge and Screening Patterns in Zuni Pueblo Women in the Southwest United States.
    J Cancer Educ. 2023 Apr 13. doi: 10.1007/s13187-023-02295.
    PubMed    
    Abstract available

  156. KAUMA G, Ddungu H, Ssewanyana I, Nyesiga S, et al
    Virologic Nonsuppression Among Patients With HIV Newly Diagnosed With Cancer at Uganda Cancer Institute: A Cross-Sectional Study.
    JCO Glob Oncol. 2023;9:e2200262.
    PubMed    
    Abstract available

  157. WANG Y, Mao Y, Wang C, Jiang X, et al
    RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer.
    Ann Med. 2023;55:2190618.
    PubMed    
    Abstract available

  158. CAO F, Zhong M, Liu CR
    [Uterine POLE mutant endometrioid carcinoma combined with human papilloma virus-associated cervical adenocarcinoma: A case report and literature review].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2023;55:370-374.
    PubMed    
    Abstract available

  159. YAKO-SUKETOMO H, Katayama K, Ogihara A, Asai-Sato M, et al
    Process of developing a cervical cancer education program for female university students in a Health and Physical Education teacher training course: an action research.
    BMC Womens Health. 2023;23:169.
    PubMed    
    Abstract available

  160. VAHABI M, Mishra G, Pimple S, Wong JP, et al
    Effectiveness of family-centred sexual health education and HPV self-sampling in promoting cervical cancer screening among hard-to-reach indian women in rural and tribal areas: a community-based pilot study.
    BMC Public Health. 2023;23:671.
    PubMed    
    Abstract available

  161. VIJAYAKUMAR S, Nittala MR, Duggar WN, King M, et al
    The Influence of Patient and System Factors on the Radiotherapy Treatment Time in the Treatment of Non-metastatic Cervical Cancer Patients in a Rural and Resource-Lean State's Safety-Net Hospital: Benefits of Strategic Planning.
    Cureus. 2023;15:e35954.
    PubMed    
    Abstract available

  162. DAHBI Z, Fadila K, Vinh-Hung V
    Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison.
    Cureus. 2023;15:e37235.
    PubMed    
    Abstract available


  163. Erratum: Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application.
    Front Oncol. 2023;13:1178841.
    PubMed    
    Abstract available

  164. LIU H, Liu J, Zhao G
    Retracted: Long non-coding RNA HOTAIR regulates proliferation, migration and invasion of human cervical cancer cells by modulating expression of MAPK1.
    Arch Med Sci. 2023;19:558.
    PubMed    
    Abstract available

  165. ZHANG SQ, Zhang J, Yu Y, Yu MM, et al
    APOBEC3B expression has prognostic significance in cervical cancer.
    Int J Clin Exp Pathol. 2023;16:48-56.
    PubMed    
    Abstract available

  166. LE TM, Chong GO, Han HS
    Tumor human papillomavirus: a potential test for cervical cancer prognosis.
    Transl Cancer Res. 2023;12:684-687.
    PubMed    


  167. HU XC, Gan CX, Zheng HM, Wu XP, et al
    Immunotherapy in combination with chemotherapy for Peutz-Jeghers syndrome with advanced cervical cancer: A case report.
    World J Gastrointest Surg. 2023;15:480-487.
    PubMed    
    Abstract available

  168. LULU B, Loha E, Agegnehu A
    Factors affecting cervical cancer screening service uptake among clients visiting the ART clinic at Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia: A cross-sectional study.
    J Cancer Policy. 2023 Apr 7:100422. doi: 10.1016/j.jcpo.2023.100422.
    PubMed    
    Abstract available

  169. CHEN M, Wang D, Bao Z, Yi Z, et al
    The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy.
    Radiat Oncol. 2023;18:66.
    PubMed    
    Abstract available

  170. HUANG J, Yang J, Zhang Y, Lu D, et al
    FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.
    Exp Cell Res. 2023;427:113585.
    PubMed    
    Abstract available

  171. CHEN H, Tian X, Luan Y, Lu H, et al
    Highly expressed circ_0000285 from serum and cervical exfoliated cells as a novel biomarker for the diagnosis of early stage-cervical cancer.
    J Obstet Gynaecol. 2023;43:2196344.
    PubMed    
    Abstract available

  172. MEI X, Zhang R, Li D, Xie X, et al
    Association between the infections of Trichomonas vaginalis and uterine cervical human papillomavirus: a meta-analysis.
    J Obstet Gynaecol. 2023;43:2194986.
    PubMed    
    Abstract available

  173. KOJALO U, Tisler A, Parna K, Kivite-Urtane A, et al
    An overview of cervical cancer epidemiology and prevention in the Baltic States.
    BMC Public Health. 2023;23:660.
    PubMed    
    Abstract available

  174. GUPTA R, Kumar N, Bansal S, Singh S, et al
    Artificial Intelligence-driven Digital Cytology-based Cervical Cancer Screening: Is the Time Ripe to Adopt This Disruptive Technology in Resource-constrained Settings? A Literature Review.
    J Digit Imaging. 2023 Apr 7. doi: 10.1007/s10278-023-00821.
    PubMed    
    Abstract available

  175. QIAN WL, Chen Q, Zhang JB, Xu JM, et al
    RESOLVE-based radiomics in cervical cancer: improved image quality means better feature reproducibility?
    Clin Radiol. 2023 Mar 21:S0009-9260(23)00093-4. doi: 10.1016/j.crad.2023.
    PubMed    
    Abstract available

  176. COLE MB, Lee EK, Frogner BK, Wright B, et al
    Changes in Performance Measures and Service Volume at US Federally Qualified Health Centers During the COVID-19 Pandemic.
    JAMA Health Forum. 2023;4:e230351.
    PubMed    
    Abstract available

  177. ALSANAFI M, Salim NA, Sallam M
    Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs.
    Hum Vaccin Immunother. 2023;19:2194772.
    PubMed    
    Abstract available

  178. ZHAO R, Sekar P, Bennis SL, Kulasingam S, et al
    A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies.
    Prev Med. 2023;170:107494.
    PubMed    
    Abstract available

  179. SU A, Liu Y, Cao X, Zhao J, et al
    Direct Virus Gene Detection: A CRISPR/dCas9-Mediated Surface-Enhanced Raman Scattering Strategy with Enzyme-Catalyzed Signal Amplification.
    Anal Chem. 2023;95:5927-5936.
    PubMed    
    Abstract available

  180. ZHU J, Yang C, Song S, Wang R, et al
    Classification of multiple cancer types by combination of plasma-based near-infrared spectroscopy analysis and machine learning modeling.
    Anal Biochem. 2023;669:115120.
    PubMed    
    Abstract available

  181. HEER E, Peters C, Knight R, Yang L, et al
    Participation, barriers, and facilitators of cancer screening among LGBTQ+ populations: A review of the literature.
    Prev Med. 2023;170:107478.
    PubMed    
    Abstract available

  182. YOSHINO A, Kobayashi E, Tsuboyama T, Fukui H, et al
    Novel Strategy for the Management of Cervical Multicystic Diseases.
    Ann Surg Oncol. 2023;30:2964-2973.
    PubMed    
    Abstract available

  183. SELBY K, Sedki M, Levine E, Kamineni A, et al
    Test performance metrics for breast, cervical, colon and lung cancer screening: a systematic review.
    J Natl Cancer Inst. 2023 Feb 8:djad028. doi: 10.1093.
    PubMed    
    Abstract available

  184. NICHOLLS EJ, McGowan CR, Miles S, Baxter L, et al
    Provision of cervical screening for transmasculine patients: a review of clinical and programmatic guidelines.
    BMJ Sex Reprod Health. 2023;49:118-128.
    PubMed    
    Abstract available

  185. BURGER E, Baussano I, Kim JJ, Laprise JF, et al
    Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions.
    Vaccine. 2022 Aug 5. pii: S0264-410X(22)00910.
    PubMed    


  186. USMAN IM, Chama N, Aigbogun EO Jr, Kabanyoro A, et al
    Knowledge, Attitude, and Practice Toward Cervical Cancer Screening Among Female University Students in Ishaka Western Uganda.
    Int J Womens Health. 2023;15:611-620.
    PubMed    
    Abstract available

  187. ZHAO Q, Wang W, Cui J
    Retraction Note: Melatonin enhances TNF-alpha-mediated cervical cancer HeLa cells death via suppressing CaMKII/Parkin/mitophagy axis.
    Cancer Cell Int. 2023;23:78.
    PubMed    


  188. NAKAMURA K, Yamashita S, Kigure K, Nishimura T, et al
    Utility of vaginal vault cytology in the local recurrence of cervical cancer.
    BMC Womens Health. 2023;23:186.
    PubMed    
    Abstract available

  189. SHEN L, Li Y, Hu G, Song X, et al
    Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFbeta/Smad2/3 signaling.
    Funct Integr Genomics. 2023;23:133.
    PubMed    
    Abstract available

  190. DOVER L, Dulaney C
    PROshot: Mepitel Film, Daily Versus Twice-Daily Radiation Therapy for Small Cell Lung Cancer, POLAR, Decipher, and Patterns of Failure After Magnetic Resonance Imaging-Guided Brachytherapy for Cervical Cancer.
    Pract Radiat Oncol. 2023;13:167-171.
    PubMed    


  191. SAND FL, Urbute A, Ring LL, Kjaer AK, et al
    The influence of overweight and obesity on participation in cervical cancer screening: A systematic review and meta-analysis.
    Prev Med. 2023 Apr 18:107519. doi: 10.1016/j.ypmed.2023.107519.
    PubMed    
    Abstract available

  192. MILESHKIN LR, Moore KN, Barnes EH, Gebski V, et al
    Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
    Lancet Oncol. 2023 Apr 17:S1470-2045(23)00147.
    PubMed    
    Abstract available

  193. LIU H, Zhang GN, Luo M, Zhang XD, et al
    [Clinicopathological features and prognostic factors of patients with lung metastasis of stage â… a~â…¢b cervical cancer].
    Zhonghua Zhong Liu Za Zhi. 2023;45:340-347.
    PubMed    
    Abstract available

  194. JIAO S, Guo L, Da F, Gao Q, et al
    Competitive Risk Model Nomogram to Predict Prognosis in Patients Aged Over 65 Years with nonmetastatic Cervical Cancer: A SEER Population-Based Study.
    Technol Cancer Res Treat. 2023;22:15330338231164191.
    PubMed    
    Abstract available

  195. SHARIFIAN K, Shoja Z, Jalilvand S
    The interplay between human papillomavirus and vaginal microbiota in cervical cancer development.
    Virol J. 2023;20:73.
    PubMed    
    Abstract available

  196. MAHIOU K, Vincent L, Peignaux-Casasnovas K, Costaz H, et al
    Impact of therapeutic strategy on disease-free and overall survival of early-stage cervical cancer: Surgery alone versus preoperative radiation.
    Cancer Rep (Hoboken). 2023 Apr 19:e1823. doi: 10.1002/cnr2.1823.
    PubMed    
    Abstract available

  197. QI ZM, Wang X, Liu X, Zhao J, et al
    Asperuloside Promotes Apoptosis of Cervical Cancer Cells through Endoplasmic Reticulum Stress-Mitochondrial Pathway.
    Chin J Integr Med. 2023 Apr 20. doi: 10.1007/s11655-023-3695.
    PubMed    
    Abstract available

  198. WANG W, Meng Q, Zhou Y, Hu K, et al
    Prophylactic extended-field irradiation versus pelvic irradiation in cervical cancer patients with 2018 FIGO stage IIIC1 disease.
    Pract Radiat Oncol. 2023 Apr 17:S1879-8500(23)00099.
    PubMed    
    Abstract available

  199. LUIZAGA CTM, Jardim BC, Wunsch Filho V, Eluf Neto J, et al
    Recent changes in trends of mortality from cervical cancer in Southeastern Brazil.
    Rev Saude Publica. 2023;57:25.
    PubMed    
    Abstract available

  200. CHEN Y, Zheng Y, Wu Y, Dai J, et al
    Local excision as a viable alternative to hysterectomy for early-stage cervical cancer in women of reproductive age: a population-based cohort study.
    Int J Surg. 2023 Apr 20. doi: 10.1097/JS9.0000000000000417.
    PubMed    
    Abstract available

  201. VOJTISEK R
    Image guided adaptive brachytherapy of cervical cancer - practical recommendations.
    Klin Onkol. 2023;36:96-103.
    PubMed    
    Abstract available

  202. GHEBRENDRIAS S, Mody S, Washington S, Hussein B, et al
    A Cervical Cancer Screening Toolkit for Somali Women: A Pilot Randomized Controlled Trial.
    J Immigr Minor Health. 2023 Apr 18:1-8. doi: 10.1007/s10903-023-01455.
    PubMed    
    Abstract available

  203. NGUYEN T, Nougaret S, Castillo P, Paspulati R, et al
    Cervical cancer in the pregnant population.
    Abdom Radiol (NY). 2023 Apr 18. doi: 10.1007/s00261-023-03836.
    PubMed    
    Abstract available

  204. LUCKETT R, Feldman S, Woo YL, Moscicki AB, et al
    Point of View: COVID-19 as a catalyst for reimagining cervical cancer prevention.
    Elife. 2023;12:e86266.
    PubMed    
    Abstract available

  205. SIDDIG EE, Ahmed A, Ahmed ES, Mohammed MA, et al
    Knowledge and attitudes towards cervical cancer prevention among women in Khartoum state, Sudan.
    Womens Health (Lond). 2023;19:17455057231166286.
    PubMed    
    Abstract available

  206. ZHAO XL, Zhao S, Xia CF, Hu SY, et al
    Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study.
    BMC Med. 2023;21:149.
    PubMed    
    Abstract available

  207. KAMANGA P, Zhang B, Stones W
    Factors associated with low utilisation of cervical cancer screening among urban women in Lilongwe, Malawi: a cross sectional study.
    BMC Womens Health. 2023;23:183.
    PubMed    
    Abstract available

  208. SY F, Berner-Rodoreda A, Asnake T, Getnet M, et al
    Exploring computer-aided health decision-making on cervical cancer interventions through deliberative interviews in Ethiopia.
    NPJ Digit Med. 2023;6:68.
    PubMed    
    Abstract available

  209. SOKALE IO, Oluyomi AO, Montealegre JR, Thrift AP, et al
    Racial/ethnic disparities in cervical cancer stage at diagnosis: Mediating effects of neighborhood-level socioeconomic deprivation.
    Cancer Epidemiol Biomarkers Prev. 2023 Apr 17:EPI-23-0038.
    PubMed    
    Abstract available

  210. ABE M, Toshiyama R, Gotoh K, Sakai K, et al
    [A Case of Sister Mary Joseph's Nodule after Radiation Therapy for Cervical Cancer].
    Gan To Kagaku Ryoho. 2023;50:535-537.
    PubMed    
    Abstract available

  211. GAO X, Yang L
    HBXIP knockdown inhibits FHL2 to promote cycle arrest and suppress cervical cancer cell proliferation, invasion and migration.
    Oncol Lett. 2023;25:186.
    PubMed    
    Abstract available

  212. LI XY, Li G, Gong TT, Lv JL, et al
    Non-Genetic Factors and Risk of Cervical Cancer: An Umbrella Review of Systematic Reviews and Meta-Analyses of Observational Studies.
    Int J Public Health. 2023;68:1605198.
    PubMed    
    Abstract available

  213. SHI H, Xiong L, Yan G, Du S, et al
    Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis.
    Front Mol Biosci. 2023;10:1156062.
    PubMed    
    Abstract available

  214. YUAN L, Lei H, Zou D, Wen B, et al
    Public health insurance and the risk of cancer-specific mortality in patients with cervical cancer: A Chinese prospective cohort study.
    Front Public Health. 2023;11:1121548.
    PubMed    
    Abstract available


  215. [Chinese expert consensus on the use of human papillomavirus nucleic acid testing for cervical cancer screening (2022)].
    Zhonghua Yi Xue Za Zhi. 2023;103:1184-1195.
    PubMed    
    Abstract available

  216. MARCHADIER A, Leleu H, Barre S
    [Budget impact of self-testing in the national cervical cancer screening program].
    Rev Epidemiol Sante Publique. 2023;71:101838.
    PubMed    
    Abstract available

  217. TERADA S, Tsunetoh S, Tanaka Y, Tanaka T, et al
    Boron uptake of boronophenylalanine and the effect of boron neutron capture therapy in cervical cancer cells.
    Appl Radiat Isot. 2023;197:110792.
    PubMed    
    Abstract available

  218. MEZA RAMIREZ CA, Greenop M, Almoshawah YA, Martin Hirsch PL, et al
    Advancing cervical cancer diagnosis and screening with spectroscopy and machine learning.
    Expert Rev Mol Diagn. 2023 Apr 19:1-16. doi: 10.1080/14737159.2023.2203816.
    PubMed    
    Abstract available

  219. DAS S, Babu A, Medha T, Ramanathan G, et al
    Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients.
    Med Oncol. 2023;40:149.
    PubMed    
    Abstract available

  220. ZHANG Z, Wan X, Lei X, Wu Y, et al
    Intra- and peri-tumoral MRI radiomics features for preoperative lymph node metastasis prediction in early-stage cervical cancer.
    Insights Imaging. 2023;14:65.
    PubMed    
    Abstract available

  221. KANG Z, Liu J, Ma C, Chen C, et al
    Early screening of cervical cancer based on tissue Raman spectroscopy combined with deep learning algorithms.
    Photodiagnosis Photodyn Ther. 2023 Apr 12:103557.
    PubMed    
    Abstract available

  222. LI R, Qu W, Liu Q, Tan Y, et al
    Development and validation of a deep learning survival model for cervical adenocarcinoma patients.
    BMC Bioinformatics. 2023;24:146.
    PubMed    
    Abstract available

  223. LOMBE DC, Mwamba M, Msadabwe S, Bond V, et al
    Delays in seeking, reaching and access to quality cancer care in sub-Saharan Africa: a systematic review.
    BMJ Open. 2023;13:e067715.
    PubMed    
    Abstract available

  224. GOTTSCHLICH A, Payne BA, Trawin J, Albert A, et al
    Community-integrated self-collected HPV-based cervix screening in a low-resource rural setting: a pragmatic, cluster-randomized trial.
    Nat Med. 2023;29:927-935.
    PubMed    
    Abstract available

  225. ODAGAMI M, Iwata A, Kubota K, Kurasawa K, et al
    Awareness of Infectious Disease Screening During Early Pregnancy and Knowledge About its Vertical Transmission in Japan: A Report from the Pregnant Women Health Initiative.
    Matern Child Health J. 2023;27:933-943.
    PubMed    
    Abstract available

  226. FINAN RR, Chemaitelly H, Racoubian E, Aimagambetova G, et al
    Genetic diversity of human papillomavirus (HPV) as specified by the detection method, gender, and year of sampling: a retrospective cross-sectional study.
    Arch Gynecol Obstet. 2023;307:1469-1479.
    PubMed    
    Abstract available

  227. RUFFIEUX Y, Muchengeti M, Olago V, Dhokotera T, et al
    Age and cancer incidence in 5.2 million people with HIV: the South African HIV Cancer Match study.
    Clin Infect Dis. 2022 Dec 3:ciac925. doi: 10.1093.
    PubMed    
    Abstract available

  228. MACKENZIE P, Vajdic C, Delaney G, Comans T, et al
    Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review.
    J Geriatr Oncol. 2023;14:101387.
    PubMed    
    Abstract available

  229. STUEBS FA, Mergel F, Koch MC, Dietl AK, et al
    Cervical intraepithelial neoplasia grade 3: development during pregnancy and postpartum.
    Arch Gynecol Obstet. 2023;307:1567-1572.
    PubMed    
    Abstract available

  230. LIU Y, Weiss K, Zamudio AR, Hayes MP, et al
    Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:932-938.
    PubMed    
    Abstract available

  231. ORNSKOV D, Waldstrom M, Thomsen LT, Munk C, et al
    Quality Control of Biospecimens in a Danish Clinical Cytology Biobank.
    Biopreserv Biobank. 2023;21:184-190.
    PubMed    
    Abstract available

  232. PAPOUTSIS D
    Improving the surgical performance during LLETZ cervical excision to optimise oncological and obstetric outcomes: critical appraisal of a novel high-fidelity simulator.
    Arch Gynecol Obstet. 2023;307:1643-1644.
    PubMed    


  233. FRANCA MC, Boyer VE, Gerend MA, Lee M, et al
    College Students' Awareness of the Link Between Human Papillomavirus (HPV) and HPV-Associated Cancers.
    J Cancer Educ. 2023;38:669-676.
    PubMed    
    Abstract available

  234. YILDIRIM KARACA S, Adiyeke M, Ince O, Ileri A, et al
    Prediction model for residual high-grade cervical intraepithelial lesions.
    Minerva Obstet Gynecol. 2023;75:158-164.
    PubMed    
    Abstract available

  235. THRALL MJ
    A Practical Approach to Squamous Abnormalities on Cervical Cytology: Overview of Interpretive Criteria and Guidance for Altering Thresholds in Response to Quality Assurance Findings.
    Acta Cytol. 2023;67:129-142.
    PubMed    
    Abstract available

  236. HOPP AM, Puzyrenko A, Giorgadze T
    Comprehensive Review of Anal Cytology.
    Acta Cytol. 2023;67:185-194.
    PubMed    
    Abstract available

  237. BARROETA JE, Lastra RR
    Cytopathology in Gynecology and Gynecologic Oncology: Updates, Recent Advances, and Practical Considerations.
    Acta Cytol. 2023;67:109-110.
    PubMed    


  238. OLIVAS AD, Barroeta JE, Lastra RR
    Overview of Ancillary Techniques in Cervical Cytology.
    Acta Cytol. 2023;67:119-128.
    PubMed    
    Abstract available

  239. ALFONZO E, Zhang C, Daneshpip F, Strander B, et al
    Accuracy of colposcopy in the Swedish screening program.
    Acta Obstet Gynecol Scand. 2023;102:549-555.
    PubMed    
    Abstract available

  240. MITTELSTADT S, Kelemen O, Admard J, Gschwind A, et al
    Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse.
    Br J Cancer. 2023 Mar 27. doi: 10.1038/s41416-023-02233.
    PubMed    
    Abstract available

  241. KAMAL M, Lameiras S, Deloger M, Morel A, et al
    Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Br J Cancer. 2023 Apr 13. doi: 10.1038/s41416-023-02261.
    PubMed    


  242. AYALA-PEACOCK DN, Chino JP
    Is it time for bone marrow sparing radiation therapy to be standard of care in cervical cancer?
    Cancer. 2023 Apr 12. doi: 10.1002/cncr.34769.
    PubMed    


  243. WANG S, Liu J, Lei K, Jia Y, et al
    Single-photon emission computed tomography-defined active bone marrow-sparing volumetric-modulated arc therapy reduces the incidence of acute hematologic toxicity in locally advanced cervical cancer patients who receive chemoradiotherapy: A single-cen
    Cancer. 2023 Apr 12. doi: 10.1002/cncr.34771.
    PubMed    
    Abstract available

  244. TOYODA S, Morita K, Ishida E, Sado T, et al
    Spindle-nucleated cells in cervical liquid-based cytology: Difficulties in distinguishing between epithelial and non-epithelial tumours based on morphology.
    Cytopathology. 2023;34:271-274.
    PubMed    
    Abstract available

  245. SEO Y, Park E, Kim HS
    Cytological features of mesonephric-like adenocarcinoma of the uterine corpus.
    Diagn Cytopathol. 2023 Feb 8. doi: 10.1002/dc.25111.
    PubMed    
    Abstract available

  246. WENZEL HHB, Hardie AN, Moncada-Torres A, Hogdall CK, et al
    A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases.
    Eur J Cancer. 2023;185:61-68.
    PubMed    
    Abstract available

  247. MOOLENAAR LR, van Rangelrooij LE, van Poelgeest MIE, van Beurden M, et al
    Clinical outcomes of pelvic exenteration for gynecologic malignancies.
    Gynecol Oncol. 2023;171:114-120.
    PubMed    
    Abstract available

  248. GARCIA-SAYRE J, Lin YG, Matuso K, Tsao-Wei DD, et al
    Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer.
    Gynecol Oncol. 2023;173:49-57.
    PubMed    
    Abstract available

  249. CIBULA D
    The group with the most heterogenous treatment among patients with cervical cancer.
    Gynecol Oncol. 2023 Apr 17:S0090-8258(23)00169.
    PubMed    


  250. HERZOG C, Vavourakis CD, Barrett JE, Karbon G, et al
    HPV-induced host epigenetic reprogramming is lost upon progression to high-grade cervical intraepithelial neoplasia.
    Int J Cancer. 2023 Feb 21. doi: 10.1002/ijc.34477.
    PubMed    
    Abstract available

  251. TISLER A, Nygard M, Kivite-Urtane A, Berza N, et al
    Comment on "The European response to the WHO call to eliminate cervical cancer as a public health problem".
    Int J Cancer. 2023 Apr 19. doi: 10.1002/ijc.34540.
    PubMed    


  252. MATSUO K, Violette CJ, Mandelbaum RS, Shoupe D, et al
    Utilizations and characteristics of ovarian conservation at hysterectomy for cervical carcinoma in-situ.
    Int J Gynaecol Obstet. 2022 Dec 1. doi: 10.1002/ijgo.14604.
    PubMed    
    Abstract available

  253. TOUHAMI O, Plante M, St-Gelais J, Frumovitz M, et al
    Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix.
    Int J Gynecol Cancer. 2023;33:623-627.
    PubMed    


  254. SOOCHIT A, Zhang C, Feng Y, Luo X, et al
    Impact of different post-operative treatment modalities on long-term outcomes in International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIICp cervical cancer.
    Int J Gynecol Cancer. 2023 Mar 31:ijgc-2022-004234.
    PubMed    
    Abstract available

  255. KESIC V, Carcopino X, Preti M, Vieira-Baptista P, et al
    The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus s
    Int J Gynecol Cancer. 2023;33:446-461.
    PubMed    
    Abstract available

  256. KAMANI MO, Kyrgiou M, Joura E, Zapardiel I, et al
    ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?
    Int J Gynecol Cancer. 2023;33:462-464.
    PubMed    


  257. GOMEZ CHEREY JF, Payalef SN, Fleider L, Reyes AP, et al
    Microbiota unbalance in relation to high-risk human papillomavirus cervical infection.
    Int J Gynecol Cancer. 2023;33:482-488.
    PubMed    
    Abstract available

  258. BOCCIOLONE L, Candotti G, Cioffi R, Rabaiotti E, et al
    Sentinel lymph node biopsy in open surgery for gynecological malignancies.
    Int J Gynecol Cancer. 2023;33:636-637.
    PubMed    


  259. RAMIREZ PT
    ESGO/ESTRO/ESP updated guidelines in cervical cancer.
    Int J Gynecol Cancer. 2023 Apr 13:ijgc-2023-004523.
    PubMed    


  260. SAGAE S, Toita T, Matsuura M, Saito M, et al
    Improvement in radiation techniques for locally advanced cervical cancer during the last two decades.
    Int J Gynecol Cancer. 2023 Apr 11:ijgc-2022-004230.
    PubMed    
    Abstract available

  261. MARAR M, Niedermayr T, Kidd E
    Developing next generation 3D-printing for cervical cancer hybrid brachytherapy: a guided interstitial technique enabling improved flexibility, dosimetry, and efficiency.
    Int J Radiat Oncol Biol Phys. 2023 Apr 12:S0360-3016(23)00364.
    PubMed    
    Abstract available

  262. CHAIKEN SR, Bruegl AS, Caughey AB, Emerson J, et al
    Adjuvant Human Papillomavirus Vaccination After Excisional Procedure for Cervical Intraepithelial Neoplasia: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2023;141:756-763.
    PubMed    
    Abstract available

  263. CAUSIN RL, Van Helvoort Lengert A, Gomes INF, De Freitas AJA, et al
    MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression.
    Oncol Rep. 2023;49:109.
    PubMed    
    Abstract available

  264. YANG J, Gao Y, Yao S, Wan S, et al
    TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1.
    Oncol Rep. 2023;49:114.
    PubMed    
    Abstract available

  265. RAHIMI M, Akbari A, Asadi F, Emami H, et al
    Cervical cancer survival prediction by machine learning algorithms: a systematic review.
    BMC Cancer. 2023;23:341.
    PubMed    
    Abstract available

  266. GAN Q, Huang X, Zhao W, Liu H, et al
    AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway.
    BMC Cancer. 2023;23:364.
    PubMed    
    Abstract available

  267. TAKADA A, Yokota H, Nemoto MW, Horikoshi T, et al
    Prognosis prediction of uterine cervical cancer using changes in the histogram and texture features of apparent diffusion coefficient during definitive chemoradiotherapy.
    PLoS One. 2023;18:e0282710.
    PubMed    
    Abstract available

  268. PAKEN J, Govender CD, Pillay M, Feyasa M, et al
    Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.
    PLoS One. 2023;18:e0283639.
    PubMed    
    Abstract available

  269. MCDERMOTT A
    Microbiome insights open new avenues to treat HPV.
    Proc Natl Acad Sci U S A. 2023;120:e2304645120.
    PubMed    



Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;